Signaling Pathways - Kidney Injury Studies - Thyroid Cancer
清除全部
- B1483 Fenoldopam中文名: 非诺多泮Target: D1 and D5 ReceptorsSummary: D1样多巴胺受体部分激动剂
- B2236 Desvenlafaxine中文名: 去甲文拉法辛Target: 5-HT Transporters|Norepinephrine transportersSummary: 5-羟色胺(5-HT)和去甲肾上腺素(NE)再摄取抑制剂
- A2174 Lenvatinib (E7080)中文名: 乐伐替尼,仑伐替尼Target: VEGFR|PDGFR|RETSummary: VEGFR抑制剂
- A3632 Motesanib中文名: 莫特塞尼Target: VEGFRSummary: Flk-1/Flt-4/PDGFR-/c-Kit抑制剂
- A3194 AST 4871 CitationTarget: RETSummary: RET激酶抑制剂
- A4346 Aminophylline中文名: 氨茶碱,氨基非林Target: Phosphodiesterases (PDEs)Summary: Pan-PDE抑制剂
- A4111 VX-680 (MK-0457,Tozasertib)中文名: 陶扎色替Target: Aurora KinasesSummary: Aurora 激酶抑制剂
- A3016 PLX-47201 CitationTarget: RafSummary: BRAF激酶抑制剂
- A3009 Sorafenib2 Citation中文名: 索拉非尼Target: Raf|VEGFRSummary: Raf激酶和酪氨酸激酶抑制剂